|
Value Addition
|
Capabilities
|
Track Record
|
Customised
Chemical
Synthesis
|
Intellectual
leverage
Bulk capacity
|
A
nucleus of reputed scientists for R&D (NCEs) |
Willingness
to invest capital |
| Intermediates |
Cost-effective
manufacturing
Cost reduction through process innovation
|
FDA
approved manufacturing plant capable of all types of reactions |
Currently
exporting intermediates to MNCs |
Active
Pharmaceutical
Ingredients
|
Patent
Extension
Cost-effective manufacturing
Cost reduction through process innovation
|
FDA
approved manufacturing plant
Capable of large number of reactions
|
Currently
exporting APIS to large MNCs |
| Formulations |
Cost-effective dosage production |
Best-in-class formulation with
Irish approval |
Willingness to invest in getting
approvals |
